| Literature DB >> 27413782 |
Yoann Cotelle1, Vincent Lebrun2, Naomi Sakai1, Thomas R Ward2, Stefan Matile1.
Abstract
In this report, we introduce artificial enzymes that operate with anion-π interactions, an interaction that is essentially new to nature. The possibility to stabilize anionic intermediates and transition states on an π-acidic surface has been recently demonstrated, using the addition of malonate half thioesters to enolate acceptors as a biologically relevant example. The best chiral anion-π catalysts operate with an addition/decarboxylation ratio of 4:1, but without any stereoselectivity. To catalyze this important but intrinsically disfavored reaction stereoselectively, a series of anion-π catalysts was equipped with biotin and screened against a collection of streptavidin mutants. With the best hit, the S112Y mutant, the reaction occurred with 95% ee and complete suppression of the intrinsically favored side product from decarboxylation. This performance of anion-π enzymes rivals, if not exceeds, that of the best conventional organocatalysts. Inhibition of the S112Y mutant by nitrate but not by bulky anions supports that contributions from anion-π interactions exist and matter, also within proteins. In agreement with docking results, K121 is shown to be essential, presumably to lower the pK a of the tertiary amine catalyst to operate at the optimum pH around 3, that is below the pK a of the substrate. Most importantly, increasing enantioselectivity with different mutants always coincides with increasing rates and conversion, i.e., selective transition-state stabilization.Entities:
Year: 2016 PMID: 27413782 PMCID: PMC4919773 DOI: 10.1021/acscentsci.6b00097
Source DB: PubMed Journal: ACS Cent Sci ISSN: 2374-7943 Impact factor: 14.553
Figure 1The concept of anion-π enzymes (top), together with structures of substrates, products (A: addition, D: decarboxylation) and conceivable reactive intermediates (RI1) and transition states (TS1). Highlighted are π surface (blue), base catalyst (blue), fixed Leonard turns (magenta), and top-down approach of 2 (bold) to deprotonated 1 on the π surface (TS1). PMP = p-methoxyphenyl.
Figure 2Structure of biotin–NDI–base triads. Note, 6 is a mixture of sulfoxide diastereoisomers.
Figure 3Selected experimental data: (A) GPC chromatograms of S121Y with (solid) and without 8 (dashed, 2 equiv), detected at 220 nm (top) and 570 nm (bottom). (B) Absorption spectrum of 8 (top) and CD spectra of S112Y with increasing concentrations of 8 (0–4 equiv, bottom). (C) Dependence of the ee with WT + 8 on pH (red, pH < 3: Gly buffer, pKa = 2.4; pH > 3: DMG buffer (3,3-dimethylglutaric acid), pKa1 = 3.7, pKa2 = 6.3), compared to the pH dependent deprotonation of MAHT 1 (cyan). (D) Dependence of ee on the conversion into 3 after 24 h at pH 3.0 with 8 and different mutants (Table , entries 16-31). (E) Conversion into 3 with time for S112Y + 8 (●, ○) and WT + 8 (□) with (●) and without (□, ○) 200 mM NaNO3. (F) Dependence of the ee with WT + 8 on the concentration of NaNO3 (●) and glucose-6-phosphate (○).
Characteristics of Anion-π Enzymes
| Cat | protein | conditions | η (%) | A/D | ||
|---|---|---|---|---|---|---|
| 1 | WT | PBS | 4 | 2.0 | 0 | |
| 2 | WT | PBS | 28 | 2.5 | 0 | |
| 3 | K121A | PBS | 16 | 2.6 | 0 | |
| 4 | K121H | PBS | 18 | 3.8 | 0 | |
| 5 | K121F | PBS | 7 | 0.4 | 0 | |
| 6 | K121E | PBS | 12 | 0.6 | 0 | |
| 7 | K121D | PBS | 14 | 2.5 | 0 | |
| 8 | S112H | PBS | 23 | 3.3 | 0 | |
| 9 | S112E | PBS | 0 | 0 | ||
| 10 | S112A | PBS | 20 | 2.3 | 0 | |
| 11 | L124V | PBS | 7 | 0.8 | 0 | |
| 12 | L124G | PBS | 20 | 2.8 | 0 | |
| 13 | WT | PBS | 54 | 5.8 | 0 | |
| 14 | WT | PBS | 37 | 7.6 | 10 | |
| 15 | WT | PBS | 3 | 1.0 | 0 | |
| 16 | WT | Gly | 60 | >30 | 41 | |
| 17 | S112A | Gly | 20 | >30 | 7 | |
| 18 | S112Y | Gly | 90 | >30 | 95 | |
| 19 | S112F | Gly | 90 | >30 | 91 | |
| 20 | S112W | Gly | 50 | >30 | 53 | |
| 21 | S112E | Gly | 71 | 18 | 63 | |
| 22 | S112K | Gly | 52 | 7 | 38 | |
| 23 | S112H | Gly | 70 | >30 | 64 | |
| 24 | K121E | Gly | 0 | nd | nd | |
| 25 | K121H | Gly | 0 | nd | nd | |
| 26 | K121F | Gly | 15 | >30 | 0 | |
| 27 | K121Y | Gly | 17 | 0.7 | 0 | |
| 28 | K121W | Gly | 23 | 4.0 | 0 | |
| 29 | K121A | Gly | 22 | 1.6 | 0 | |
| 30 | L124F | Gly | 68 | >30 | 60 | |
| 31 | L124Y | Gly | 30 | 1.6 | 0 | |
| 32 | S112Y | Gly | 33 | 2.5 | 33 | |
| 33 | S112Y | Gly | 0 | nd | nd | |
| 34 | S112Y | Gly | 32 | 6.4 | 0 | |
| 35 | S112Y | Gly | 41 | 10 | 0 | |
| 36 | (±)- | S112Y | Gly | 83 | >30 | 90 |
| 37 | (±)- | WT | Gly | 38 | >30 | 20 |
| 38 | Gly | 0 | nd | nd | ||
| 39 | WT | Gly | 0 | nd | nd | |
| 40 | S112Y | Gly | 0 | nd | nd |
Catalysts, see Figure ; 6 was used as mixture of sulfoxide stereoisomers.[3,33]
Streptavidin, WT = wild type.
5 mM 1, 50 mM 2, 500 μM catalyst (10 mol %), 1 mM protein (20 mol %), rt; PBS: PBS buffer/CD3CN 1:1 (PBS = phosphate buffered saline, 274 mM NaCl, 5.4 mM KCl, 20 mM phosphate, pH 7.4). Gly: Gly/CD3CN 1:1 (Gly = 50 mM glycine buffer, pH 3.0).
Conversion into 3; after 24 h.
As d; but after 96 h.
Ratio of addition product A (3)/decarboxylation product D (4).
Enantiomeric excess. (S)-3 was always the preferred enantiomer.
Figure 4Docking simulations of S112Y dimers with 8, zoomed on the active site. Protein surfaces are rendered with their electrostatic potential (red: negative, blue: positive, green: aromatics), β sheets as faint green arrows. Exposed parts of 8 are in wireframe presentation, C green, N, blue, S yellow, O red.